Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have heard of it until recently. RSV causes infections of the lungs and ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents e ...

In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can ...

Vaccines against both viruses, however, have been difficult to design. Now, scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design vaccines that ...

Vaccines against both viruses, however, have been difficult to design. Now, Scripps Research scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better ...

with an increased risk for severe RSV had ever received an RSV vaccine. There was variation seen in coverage by jurisdiction and demographic characteristics, with younger adults and those without ...